ES2058265T3 - Piperidinas antagonistas de opiaceos. - Google Patents

Piperidinas antagonistas de opiaceos.

Info

Publication number
ES2058265T3
ES2058265T3 ES88303302T ES88303302T ES2058265T3 ES 2058265 T3 ES2058265 T3 ES 2058265T3 ES 88303302 T ES88303302 T ES 88303302T ES 88303302 T ES88303302 T ES 88303302T ES 2058265 T3 ES2058265 T3 ES 2058265T3
Authority
ES
Spain
Prior art keywords
substituted
alkyl
piperidines
alquilo
hydrogen
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES88303302T
Other languages
English (en)
Inventor
Charles Howard Mitch
Dennis Michael Zimmerman
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Eli Lilly and Co
Original Assignee
Eli Lilly and Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Eli Lilly and Co filed Critical Eli Lilly and Co
Application granted granted Critical
Publication of ES2058265T3 publication Critical patent/ES2058265T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/08—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms
    • C07D211/10—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with radicals containing only carbon and hydrogen atoms attached to ring carbon atoms
    • C07D211/14—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with radicals containing only carbon and hydrogen atoms attached to ring carbon atoms with hydrocarbon or substituted hydrocarbon radicals attached to the ring nitrogen atom
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D409/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/10—Antioedematous agents; Diuretics
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/08—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms
    • C07D211/18—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D211/20—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms with hydrocarbon radicals, substituted by singly bound oxygen or sulphur atoms
    • C07D211/22—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms with hydrocarbon radicals, substituted by singly bound oxygen or sulphur atoms by oxygen atoms

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Hematology (AREA)
  • Neurosurgery (AREA)
  • Diabetes (AREA)
  • Neurology (AREA)
  • Obesity (AREA)
  • Pain & Pain Management (AREA)
  • Child & Adolescent Psychology (AREA)
  • Addiction (AREA)
  • Psychiatry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
  • Plural Heterocyclic Compounds (AREA)

Abstract

LA INVENCION PRESENTA PIPERIDINAS TRANS-3,4 1-SUSTITTUIDAS-3SUSTITUIDAS-4-METIL-4-(3-FENIL-SUSTIUIDAS) COMO ANTAGONISTAS OPIOIDES CAPACES DE BLOQUEAR LOS RECEPTORES MU Y KAPPA EN EL CEREBRO, DE FORMULA (I) DONDE R1 ES HIDROGENO O ALCANOILO C1-C4; R2 ES HIDROGENO, ALQUILO C1-C4 O ALQUENILO C2-C6; R3 ES CICLOALQUILO C4-C8, CICLOALQUENILO C4-C8, ALQUILO C1-C6,ALQUENILO C2-C6, ALQUILO C1-C4 SUSTITUIDO, CICLOALQUILO C4-C8, ALQUILO C1-C4, CICLOALQUENILO C4-C8 SUSTITUIDO O TIOFENO; Z ES (II), (III) O UN ENLACE; R4 ES HIDROGENO, ALQUILO C1-C6 (IV) O (V) R5 ES ALQUILO, ALQUILO C1-C4 O (VI) N ES 1, 2 O 3, O UNA SAL FARMACOLOGICAMENTE ACEPTABLE DE DELLOS.
ES88303302T 1987-04-16 1988-04-13 Piperidinas antagonistas de opiaceos. Expired - Lifetime ES2058265T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US3912187A 1987-04-16 1987-04-16

Publications (1)

Publication Number Publication Date
ES2058265T3 true ES2058265T3 (es) 1994-11-01

Family

ID=21903800

Family Applications (1)

Application Number Title Priority Date Filing Date
ES88303302T Expired - Lifetime ES2058265T3 (es) 1987-04-16 1988-04-13 Piperidinas antagonistas de opiaceos.

Country Status (21)

Country Link
EP (1) EP0287339B1 (es)
JP (1) JP2661699B2 (es)
KR (1) KR960015087B1 (es)
CN (1) CN1017992B (es)
AR (1) AR245933A1 (es)
AT (1) ATE110057T1 (es)
AU (1) AU596290B2 (es)
CA (1) CA1321792C (es)
DE (1) DE3851081T2 (es)
DK (1) DK204388A (es)
EG (1) EG18864A (es)
ES (1) ES2058265T3 (es)
HU (1) HU202492B (es)
IE (1) IE64508B1 (es)
IL (1) IL86061A (es)
MX (1) MX11117A (es)
NZ (1) NZ224236A (es)
PH (1) PH24752A (es)
PT (1) PT87233B (es)
SU (1) SU1598869A3 (es)
ZA (1) ZA882640B (es)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0299549A3 (en) * 1987-07-09 1989-02-08 Duphar International Research B.V Tertiary 2,5-dialkyl-3-phenyl-piperidine derivatives having opiate-antagonistic activity
ZA922180B (en) * 1991-03-29 1993-09-27 Lilly Co Eli Piperidine derivatives
GB9202238D0 (en) * 1992-02-03 1992-03-18 Wellcome Found Compounds
US5807858A (en) * 1996-06-05 1998-09-15 Delta Pharmaceutical, Inc. Compositions and methods for reducing respiratory depression
US5985880A (en) * 1996-06-05 1999-11-16 Delta Pharmaceuticals Compositions and methods for reducing respiratory depression and attendant side effects of mu opioid compounds
US5681830A (en) * 1992-02-03 1997-10-28 Delta Pharmaceuticals, Inc. Opioid compounds
US5574159A (en) * 1992-02-03 1996-11-12 Delta Pharmaceuticals, Inc. Opioid compounds and methods for making therefor
HU221726B1 (hu) * 1993-07-30 2002-12-28 Ardent Pharmaceuticals Inc. Piperazinszármazékok, e vegyületeket tartalmazó gyógyászati készítmények és eljárás a vegyületek előállítására
GB9725114D0 (en) * 1997-11-28 1998-01-28 Pfizer Ltd Treatment of pruritus
GB9810671D0 (en) * 1998-05-18 1998-07-15 Pfizer Ltd Anti-pruritic agents
GB9815618D0 (en) * 1998-07-18 1998-09-16 Univ Manchester Treatment of dyskinesia
TWI244481B (en) 1998-12-23 2005-12-01 Pfizer 3-azabicyclo[3.1.0]hexane derivatives useful in therapy
GB9912411D0 (en) * 1999-05-28 1999-07-28 Pfizer Ltd Compounds useful in therapy
GB9912413D0 (en) 1999-05-28 1999-07-28 Pfizer Ltd Compounds useful in therapy
GB9912410D0 (en) * 1999-05-28 1999-07-28 Pfizer Ltd Compounds useful in therapy
GB9912416D0 (en) * 1999-05-28 1999-07-28 Pfizer Ltd Compounds useful in therapy
GB9912415D0 (en) * 1999-05-28 1999-07-28 Pfizer Ltd Compounds useful in therapy
GB9912417D0 (en) * 1999-05-28 1999-07-28 Pfizer Ltd Compounds useful in therapy
MXPA02005335A (es) * 1999-11-29 2003-01-28 Adolor Corp Metodos y composiciones novedosos que incluyen opioides y antagonistas de los mismos.
GB0015562D0 (en) * 2000-06-23 2000-08-16 Pfizer Ltd Heterocycles
JP4155522B2 (ja) 2001-10-22 2008-09-24 ファイザー・プロダクツ・インク オピオイド受容体アンタゴニストとしての３−アザビシクロ（３．１．０）ヘキサン誘導体
SI2208727T1 (sl) * 2002-09-19 2012-11-30 Lilly Co Eli Diaril etri kot antagonisti opioidnega receptorja
US7538110B2 (en) 2005-10-27 2009-05-26 Adolor Corporation Opioid antagonists
IN2014DN00137A (es) * 2011-07-18 2015-05-22 Adolor Corp

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AR206937A1 (es) * 1974-09-06 1976-08-31 Lilly Co Eli Procedimiento para preparar compuestos de 1-sustituido-4-alquil-4-fenil-piperidina

Also Published As

Publication number Publication date
AR245933A1 (es) 1994-03-30
ATE110057T1 (de) 1994-09-15
DK204388D0 (da) 1988-04-14
JPS63277661A (ja) 1988-11-15
ZA882640B (en) 1989-12-27
DK204388A (da) 1989-01-05
PH24752A (en) 1990-10-01
NZ224236A (en) 1990-08-28
KR960015087B1 (ko) 1996-10-24
IE881125L (en) 1988-10-16
SU1598869A3 (ru) 1990-10-07
DE3851081D1 (de) 1994-09-22
CA1321792C (en) 1993-08-31
EP0287339B1 (en) 1994-08-17
EP0287339A3 (en) 1991-05-15
CN1017992B (zh) 1992-08-26
PT87233A (pt) 1988-05-01
DE3851081T2 (de) 1995-02-16
EP0287339A2 (en) 1988-10-19
JP2661699B2 (ja) 1997-10-08
MX11117A (es) 1993-11-01
PT87233B (pt) 1992-07-31
EG18864A (en) 1995-06-29
IL86061A (en) 1992-07-15
KR880012551A (ko) 1988-11-28
AU1462488A (en) 1988-10-20
IE64508B1 (en) 1995-08-09
CN88102191A (zh) 1988-11-02
IL86061A0 (en) 1988-09-30
HUT46892A (en) 1988-12-28
AU596290B2 (en) 1990-04-26
HU202492B (en) 1991-03-28

Similar Documents

Publication Publication Date Title
ES2058265T3 (es) Piperidinas antagonistas de opiaceos.
ES2072096T3 (es) 4-fenilpiperidinas n-sustituidas antagonistas de opioides.
ES2055523T3 (es) Agentes antifungicos de triazol.
ES2162061T3 (es) Derivados de piperidina como antagonistas de la neuroquinina.
ES2143238T3 (es) Derivados de 1-(piperidinil disustituido en posiciones 1,2)-piperazinas sustituidas en posicion 4.
ES2053508T3 (es) Compuestos de acidos 3-pirrolidinil-tio-1-azabiciclo(3.2.0)hept-2-eno-2-carboxilicos.
FI954105A (fi) Uusia 4-aminopyridiinejä, niiden valmistusmenetelmä sekä näitä yhdisteitä sisältäviä lääkkeitä
AR029216A1 (es) Compuestos inhibidores no peptidicos de la union celular dependiente de vla-4 utiles en el tratamiento de enfermedades inflamatorias, autoinmunes y respiratorias; composicion farmaceutica y procedimiento de tratamiento
ES2059408T3 (es) Un proceso para la preparacion de un compuesto.
ES2096936T3 (es) Agentes antianginales de piridopirimidinona.
ES2162668T3 (es) Derivados de bifenilo o de fenil-piridina sustituidos, su procedimiento de preparacion y composiciones farmaceuticas que los contienen.
EP0638567A4 (en) ADENOSINE INHIBITORS.
AR030507A1 (es) Compuesto de pirazolopiridina y los usos farmaceuticos del mismo
ES2048109A1 (es) Procedimiento de preparacion de nuevos derivados piperidicos del bencimidazol.
ES2075350T3 (es) Compuestos heterociclicos antiemeticos y supresores de la migraña, y composiciones farmaceuticas que los contienen.
ES2059804T3 (es) Procedimiento de preparacion de eteres de oxima de propenona.
NO20025641D0 (no) Substituerte 1-aminoalkyl-laktamer og deres anvendelse som muscarin-reseptor-antagonister
ES2087097T3 (es) Derivados de acidos fenilcarboxilicos que contienen un heterociclo.
TW333527B (en) Benzimidazoles, pharmaceutical compositions containing these compounds and processes for preparing them
MX9701955A (es) Antagonistas de neuroquinina.
ES2062425T3 (es) Piridinas, procedimientos de preparacion y medicamentos que las contienen.
ES2043863T3 (es) Procedimiento para preparar derivados de la 1,2,5,6-tetrahidropiridina.
ES2108595B1 (es) Derivados de la 3(2h)-piridacinona y procedimiento para su preparacion.
PE20030517A1 (es) Composicion fungicida a base de al menos un derivado de piridil-metil-benzamida y de al menos un derivado ditio-carbamato
ES2029879T3 (es) Procedimiento para producir derivados de aminas sustituidas.

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 287339

Country of ref document: ES